MAT2A and neoplasm: Immune-related signaling pathways were activated by MAT2A inhibition (Figure S13D), but signaling pathways associated with tumor progression, such as cell cycle, DNA repair, R loop disassembly, methylation, methionine biosynthetic process, and histone methylation, were downregulated in response to MAT2A inhibition (Figure S13E).